Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

Meridian Small Cap Growth Fund's investment thesis on Veracyte Inc ($VCYT) — Q1 2025 | Buyside Digest

All Pitches

View Letter Analysis

$VCYTNASDAQVeracyte Inc

BULL

Meridian Small Cap Growth Fund—VCYT

Fund Letter

Q1 2025

Published March 31, 2025

View Fund Profile

$46.27USD

+8.8% vs last month

$28.95Pitched

+59.8% since pitch

Market Cap$3.7B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

Veracyte is a cancer diagnostics developer whose shares dropped following news of potentially ending funding for its loss-making French subsidiary. The manager considers...

— Chad Meade

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $VCYT, and what else Meridian Small Cap Growth Fund is buying.

Other pitches on $VCYT

Other investors who've written on Veracyte Inc

No other institutional pitches found for this ticker yet.

View all $VCYT pitches →